البحث العلمي في دولة الإمارات

Alopecia Areata Post-Alemtuzumab in MS

نُشرت في الجمعة، 1 ديسمبر 2023

A Case of Alopecia Areata Following Alemtuzumab in a Patient with Multiple Sclerosis

This case report details a 33-year-old male with relapsing-remitting multiple sclerosis who developed alopecia areata in his beard two years after his second alemtuzumab cycle. While alemtuzumab is known for triggering secondary autoimmune conditions, alopecia areata remains a rare and delayed side effect. Infectious and autoimmune causes were ruled out, and the condition was confirmed by a dermatologist. Treatment with local steroids showed partial improvement. This case adds to the growing evidence of delayed autoimmune manifestations linked to alemtuzumab therapy.

البحوث ذات الصلة

اعرف المزيد
Switching from Fingolimod/Natalizumab to Cladribine Without Rebound
الجمعة، 1 ديسمبر 2023

Switching from Fingolimod/Natalizumab to Cladribine Without Rebound

اعرف المزيد
اعرف المزيد
Adherence Challenges for High-Efficacy MS Therapies
الجمعة، 22 مايو 2020

Adherence Challenges for High-Efficacy MS Therapies

اعرف المزيد
اعرف المزيد
Living with MS: A Biopsychosocial Perspective
الثلاثاء، 17 أغسطس 2021

Living with MS: A Biopsychosocial Perspective